Table 2.

Treatment Practice Patterns in Hypertension Treatment at Community Health Centers Compared with Private Practice

	Community Health Center Weighted %(SE)	Private Practice Weighted % (SE)	Unadjusted OR (95% CI)	Adjusted OR (95% CI)
New antihypertensive medication prescribed during visits with uncontrolled HTNb	18.3% (1.9)	16.2% (0.8)	1.2 (0.9–1.5)	1.6 (1.1–2.4)
Prevalent use of fixed‐dose combination drugs in patients taking ≥2 BP medicationsc	17.1% (2.2)	24.6% (0.9)	0.6 (0.4–0.9)	0.6 (0.4–0.9)a
Prevalent use of thiazide in patients with uncontrolled BP on ≥3 BP medicationsc	60.6% (7.2)	64.5% (1.8)	0.8 (0.4–1.6)	0.7 (0.4–1.5)
Prevalent use of aldosterone antagonists for resistant hypertension	2.1% (0.8)	1.5% (0.4)	1.4 (0.6–3.2)	N/A

^a p‐value <.05.

^bAdjusted for age, gender, race, geographic region, type of insurance, history of diabetes, history of ischemic heart disease, history of congestive heart failure, number of comorbid conditions, hypertension listed as a reason for the visit, systolic and diastolic BP, number of BP medications currently taking, number of comorbid conditions, number of visits in the previous 12 months, and number of nonmedication treatment or services provided, and percent poverty in patient's zip code.

^cAdjusted for age, gender, race, geographic region, type of insurance, history of diabetes, history of ischemic heart disease, history of congestive heart failure, and number of comorbid conditions.

OR compares the likelihood of use at CHC with private practice as the reference group.

Prevalent use = medication listed as either continued or newly prescribed; each component of a fixed‐dose combination drug is counted as one BP medication.

BP, blood pressure.